Dar Zavain 4

4 · RECURSION PHARMACEUTICALS, INC. · Filed Jul 3, 2025

Insider Transaction Report

Form 4
Period: 2025-07-01
Dar Zavain
Director
Transactions
  • Award

    Class A Common Stock

    2025-07-01+2,924135,817 total
Footnotes (1)
  • [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.

Documents

1 file
  • 4
    wk-form4_1751571010.xmlPrimary

    FORM 4